BEND2

gene
On this page

Also known as MGC33653

Summary

BEND2 (BEN domain containing 2, HGNC:28509) is a protein-coding gene on chromosome Xp22.13, encoding BEN domain-containing protein 2 (Q8NDZ0).

This gene encodes a protein which has two BEN domains in the C-terminus. These domains are found in proteins which participate in protein and DNA interactions which occur during chromatin restructuring or transcription. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 139105 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 145 total — 1 pathogenic, 1 likely-pathogenic
  • MANE Select transcript: NM_153346

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28509
Approved symbolBEND2
NameBEN domain containing 2
LocationXp22.13
Locus typegene with protein product
StatusApproved
AliasesMGC33653
Ensembl geneENSG00000177324
Ensembl biotypeprotein_coding
OMIM301150
Entrez139105

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000380030, ENST00000380033

RefSeq mRNA: 2 — MANE Select: NM_153346 NM_001184767, NM_153346

CCDS: CCDS14184, CCDS55375

Canonical transcript exons

ENST00000380033 — 14 exons

ExonStartEnd
ENSE000012754191818051018180650
ENSE000012754271821377418213911
ENSE000012754401817100118171204
ENSE000012754471817403018174258
ENSE000012754561817597218176093
ENSE000012754641817756918177769
ENSE000012754771819100118191108
ENSE000012754821819529618195442
ENSE000012754911820181518201940
ENSE000012754961820350118203915
ENSE000012755011821256518212680
ENSE000012755321821652118216733
ENSE000014834891816293118165223
ENSE000019103011822072618220886

Expression profiles

Bgee: expression breadth broad, 30 present calls, max score 86.19.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0201 / max 21.6521, expressed in 3 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1985870.01023
1985860.00993

Top tissues by expression

210 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
monocyteCL:000057686.19gold quality
leukocyteCL:000073884.66gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.18gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099165.56gold quality
bloodUBERON:000017864.40gold quality
right testisUBERON:000453463.41gold quality
testisUBERON:000047363.19gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451162.88gold quality
left testisUBERON:000453360.91gold quality
granulocyteCL:000009460.89gold quality
lower lobe of lungUBERON:000894959.86silver quality
superficial temporal arteryUBERON:000161459.27gold quality
trabecular bone tissueUBERON:000248358.69silver quality
epithelium of nasopharynxUBERON:000195157.97gold quality
bone marrow cellCL:000209257.28gold quality
bone marrowUBERON:000237155.47silver quality
amniotic fluidUBERON:000017355.15gold quality
myocardiumUBERON:000234955.09gold quality
spermCL:000001954.84gold quality
oocyteCL:000002354.62gold quality
esophagus squamous epitheliumUBERON:000692053.31gold quality
cartilage tissueUBERON:000241853.21gold quality
Brodmann (1909) area 23UBERON:001355453.05gold quality
nasal cavity epitheliumUBERON:000538451.80gold quality
middle temporal gyrusUBERON:000277151.69gold quality
gingival epitheliumUBERON:000194951.47gold quality
caput epididymisUBERON:000435851.29gold quality
adult organismUBERON:000702350.51gold quality
corpus epididymisUBERON:000435949.99gold quality
cauda epididymisUBERON:000436049.49gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.23
E-ENAD-27no15.55

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

73 targeting BEND2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-340-5P100.0072.504437
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-656-3P100.0072.152788
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-3163100.0077.238605
HSA-MIR-511-3P99.9968.851467
HSA-MIR-366299.9973.825684
HSA-MIR-480399.9871.993117
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-9-3P99.9670.882068
HSA-MIR-391099.9571.132227
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-314399.9371.963104
HSA-MIR-205-3P99.9269.923165
HSA-MIR-380-3P99.8970.181978
HSA-MIR-391999.8769.452489
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-5003-3P99.8569.292517
HSA-MIR-548AC99.8470.774351
HSA-MIR-548H-3P99.8470.804349
HSA-MIR-548Z99.8470.804349
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-6885-3P99.7570.363187
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-494-3P99.7071.452795
HSA-MIR-128399.6972.423009
HSA-MIR-4690-5P99.6566.24813

Literature-anchored findings (GeneRIF, showing 3)

  • Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration. (PMID:31863478)
  • EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma. (PMID:34825267)
  • Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. (PMID:36604386)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioselenonENSDARG00000033616
danio_reriozgc:113423ENSDARG00000058978
mus_musculusBend2ENSMUSG00000108981
rattus_norvegicusAABR07037896.1ENSRNOG00000058952

Paralogs (2): SELENON (ENSG00000162430), HOATZ (ENSG00000183644)

Protein

Protein identifiers

BEN domain-containing protein 2Q8NDZ0 (reviewed: Q8NDZ0)

All UniProt accessions (1): Q8NDZ0

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

Isoforms (2)

UniProt IDNamesCanonical?
Q8NDZ0-11yes
Q8NDZ0-22

RefSeq proteins (2): NP_001171696, NP_699177* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR018379BEN_domainDomain

Pfam: PF10523

UniProt features (16 total): region of interest 4, compositionally biased region 3, domain 2, splice variant 2, sequence variant 2, sequence conflict 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NDZ0-F149.940.16

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 31 (showing top): chrXp22, ZNF146_TARGET_GENES, ZNF8_TARGET_GENES, MIR340_5P, MIR656_3P, MIR3910, MIR5003_3P, MIR450A_1_3P, MIR7113_5P, MIR371A_5P, MIR513B_3P, MIR190B_3P, MIR4468, MIR5587_5P, MIR141_5P

GO Biological Process (0):

GO Molecular Function (2): DNA binding (GO:0003677), protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nucleic acid binding1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

484 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
BEND2MN1Q10571687
BEND2BANPQ8N9N5570
BEND2BEND4Q6ZU67530
BEND2BEND5Q7L4P6507
BEND2CXXC5Q7LFL8448
BEND2BEND6Q5SZJ8433
BEND2MAGEB17A8MXT2429
BEND2ZNF195O14628407
BEND2ZNF850A8MQ14403
BEND2NEK4P51957400
BEND2ZNF394Q53GI3398
BEND2RAI2Q9Y5P3398
BEND2ZFTAC9JLR9397
BEND2EWSR1Q01844394
BEND2CMC2Q9NRP2371

IntAct

21 interactions, top by confidence:

ABTypeScore
BEND2ANAPC11psi-mi:“MI:0915”(physical association)0.560
BEND2ZMYM6psi-mi:“MI:0915”(physical association)0.560
ANAPC11BEND2psi-mi:“MI:0915”(physical association)0.560
PRR20DBEND2psi-mi:“MI:0915”(physical association)0.560
SF3A2BEND2psi-mi:“MI:0915”(physical association)0.560
LHX2BEND2psi-mi:“MI:0915”(physical association)0.560
ZMYM6BEND2psi-mi:“MI:0915”(physical association)0.560
BEND2ECE1psi-mi:“MI:0915”(physical association)0.370
ECE1BEND2psi-mi:“MI:0915”(physical association)0.370
ATG16L1ESYT2psi-mi:“MI:0914”(association)0.350
BEND2PRR20Dpsi-mi:“MI:0915”(physical association)0.000
BEND2SF3A2psi-mi:“MI:0915”(physical association)0.000
BEND2LHX2psi-mi:“MI:0915”(physical association)0.000
BEND2ATXN1psi-mi:“MI:0915”(physical association)0.000

BioGRID (11): BEND2 (Two-hybrid), BEND2 (Two-hybrid), BEND2 (Two-hybrid), BEND2 (Two-hybrid), PRR20B (Two-hybrid), PRR20A (Two-hybrid), PRR20D (Two-hybrid), PRR20C (Two-hybrid), PRR20E (Two-hybrid), BEND2 (Two-hybrid), APP (Reconstituted Complex)

ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9

Diamond homologs: A0A096LPI5, A6NIU2, A6NJG6, F2Z398, P0DTE4, P51957, Q09FC8, Q5H9K5, Q5T7P6, Q68CZ1, Q6B4Z3, Q6UX73, Q86U02, Q8IV13, Q8N7M2, Q8N9N2, Q8NDZ0, Q8NEM8, Q8TDM0, Q92918, Q96J02, Q96MD7, Q9BUA6, Q9NXG0, O14607, O14628, O15054, O15550, O70546, P79457, Q5NCY0, Q8N769, A7MCS3, Q3UST5, Q3ZCU0, Q8IUI4, Q08DX0, Q8TEQ0, Q9D3S3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

145 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic1
Uncertain significance73
Likely benign17
Benign5

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
584356NC_000023.10:g.(?17393861)(18671684_?)delPathogenic
2685694GRCh37/hg19 Xp22.13(chrX:18235875-18523090)x1Likely pathogenic

SpliceAI

2683 predictions. Top by Δscore:

VariantEffectΔscore
X:18171016:T:Cdonor_gain1.0000
X:18171071:TTGG:Tdonor_gain1.0000
X:18171201:TAGC:Tacceptor_gain1.0000
X:18171202:AGCCT:Aacceptor_loss1.0000
X:18171204:CCTAG:Cacceptor_loss1.0000
X:18171205:C:CAacceptor_loss1.0000
X:18171205:C:CCacceptor_gain1.0000
X:18171206:T:Aacceptor_loss1.0000
X:18174023:AACT:Adonor_loss1.0000
X:18174028:A:ACdonor_gain1.0000
X:18174028:ACT:Adonor_gain1.0000
X:18174028:ACTC:Adonor_gain1.0000
X:18174029:C:CCdonor_gain1.0000
X:18174029:CT:Cdonor_gain1.0000
X:18174029:CTC:Cdonor_gain1.0000
X:18174029:CTCC:Cdonor_gain1.0000
X:18174029:CTCCA:Cdonor_gain1.0000
X:18174031:C:CAdonor_gain1.0000
X:18174262:T:TCacceptor_gain1.0000
X:18175970:A:ACdonor_gain1.0000
X:18175971:C:CTdonor_gain1.0000
X:18176090:TATT:Tacceptor_gain1.0000
X:18177564:CATA:Cdonor_loss1.0000
X:18177565:ATACC:Adonor_loss1.0000
X:18177566:TACC:Tdonor_loss1.0000
X:18177568:C:CTdonor_loss1.0000
X:18177568:CCT:Cdonor_gain1.0000
X:18177766:TAGC:Tacceptor_gain1.0000
X:18177767:AGC:Aacceptor_gain1.0000
X:18177768:GC:Gacceptor_gain1.0000

AlphaMissense

5281 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:18165168:C:AW747C0.998
X:18165168:C:GW747C0.998
X:18165170:A:GW747R0.996
X:18165170:A:TW747R0.996
X:18171092:G:CF698L0.995
X:18171092:G:TF698L0.995
X:18171094:A:GF698L0.995
X:18165217:A:GL731P0.993
X:18165169:C:GW747S0.992
X:18165219:G:CF730L0.991
X:18165219:G:TF730L0.991
X:18165221:A:GF730L0.991
X:18171108:A:GL693P0.991
X:18171117:G:TA690D0.990
X:18171006:A:GL727P0.989
X:18176038:C:AW562C0.988
X:18176038:C:GW562C0.988
X:18171182:T:AR668S0.987
X:18171182:T:GR668S0.987
X:18176087:A:GL546P0.987
X:18171030:A:TL719H0.986
X:18171003:C:GR728P0.985
X:18171096:A:GL697P0.985
X:18171093:A:GF698S0.984
X:18171118:C:GA690P0.984
X:18171195:C:TG664E0.984
X:18176040:A:GW562R0.984
X:18176040:A:TW562R0.984
X:18171009:G:TA726D0.983
X:18171057:C:AG710V0.983

dbSNP variants (sampled 300 via entrez): RS1000120610 (X:18211893 T>C,G), RS1000181111 (X:18202044 C>A), RS1000184859 (X:18186949 A>G), RS1000189734 (X:18164695 T>C), RS1000247783 (X:18174744 C>T), RS1000345371 (X:18214156 G>A), RS1000457704 (X:18207508 A>G), RS1000487340 (X:18207192 C>T), RS1000522482 (X:18190197 A>G), RS1000627341 (X:18217887 C>T), RS1000643124 (X:18217239 T>C), RS1000783994 (X:18216635 T>C), RS1000844960 (X:18168330 T>C), RS1000919560 (X:18205402 A>G), RS1000963918 (X:18189236 G>C)

Disease associations

OMIM: gene MIM:301150 | disease phenotypes: MIM:300672

GenCC curated gene-disease

Mondo (1): developmental and epileptic encephalopathy, 2 (MONDO:0010396)

Orphanet (3): Early infantile developmental and epileptic encephalopathy (Orphanet:1934), West syndrome (Orphanet:3451), CDKL5-deficiency disorder (Orphanet:505652)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

MeSH disease descriptors (1)

DescriptorNameTree numbers
C564064CDKL5 deficiency disorder (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases methylation, increases methylation2
triphenyl phosphateaffects expression1
Air Pollutants, Occupationalincreases expression1
Arsenicaffects methylation1
Nickelincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.